Promega Corp

2800 Woods Hollow Rd,
Madison,
WI 53711
United States of America
Tel: 608-298-4650
Fax:
Email Us

Promega Corporation is a leading supplier of cell viability, cytotoxicity, apoptosis and P450 reagents for use in ADMET testing. Many of the assays are luminescence-based and provide unparalleled sensitivity and ease of use especially for high throughput applications.

Further Information: http://www.promega.com/applications/cellprolif/

Related Products

New Promega GoTaq® qPCR Master Mix Excels in Sensitivity and Stability
Real-time PCR methods can detect even smaller changes and rare events with the new Promega GoTaq qPCR Master Mix.

Promega ProteasMAX Improves Protein Characterization
Company has designed the ProteasMAX has been designed to enhance the enzymatic performance of trypsin and other proteases in preparation for MS/LC analysis.

New Promega GoTaq® qPCR Master Mix Excels in Sensitivity and Stability
Real-time PCR methods can detect even smaller changes and rare events with the new Promega GoTaq qPCR Master Mix.

Monitor Toxicity, Anti-Cancer Drug Efficacy and Cytokine Response with New Bioluminescent Cytotoxicity Technology
Promega has announced the launch of the CytoTox-Glo™ Cytotoxicity Assay at the 5th annual Screening Europe conference and exhibition.

Related news from our archive

Promega and Leica Microsystems Sign Agreement to Develop Fluorescent Ligands
Promega will develop fluorescent ligands for its HaloTag fusion proteins, to label proteins within live cells so that they can be visualized with Leica’s TCS STED.

Promega Enters into Agreement with GeneCopoeia
The companies collaborate to deliver cloned gene content ready for multiple proteomics applications.

Promega SABiosciences Agreement Enables the Most Sensitive Tools for Pathway Analysis
The Companies combine their offerings to provide sensitive tools for interrogation specific cellular pathways via transcription factor reporters.